Reading KIDS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KIDS free→Reading KIDS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track KIDS free→QuarterlyIQ Insights · KIDS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 30, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended March 31, 2026 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended March 31, 2026, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, includi…
ENTRY INTO OR AMENDMENT OF A MATERIAL DEFINITIVE AGREEMENT. On March 31, 2026, OrthoPediatrics Corp. (the “Company”) and its wholly owned domestic subsidiaries, as borrowers (collectively, the “Credit Parties”), entered into a First Amendment (the “Amendment”) to that certain Credit Agreement and Guaranty (the “Term Loan Agreement”) dated August 5, 2024, by and among the Credit Parties, any additional borrowers from time to time party thereto, any guarantors from time to time party thereto, o…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth in
Results of Operations and Financial Condition. On February 26, 2026, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter and year ended December 31, 2025, providing management's projection of 2026 revenue, EBITDA and break-even cash flow, and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter and year ended December 31, 2025, and other financial data) is furnis…
of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The financial information set forth in this Form 8-K reflects the Company's current preliminary net revenue and free cash flow estimates, is subject to the completi…
Results of Operations and Financial Condition. On October 28, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended September 30, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended September 30, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.0…
of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The financial information set forth in this Form 8-K reflects the Company's current preliminary net revenue estimates, is subject to the completion of its audit pro…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 7, 2025, the Board of Directors (the “Board”) of OrthoPediatrics Corp. (the “Company”) accepted the resignation of Terry Schlotterback as a member of the Board due to his retirement, which became effective August 8, 2025. Mr. Schlotterback’s resignation was not a result of any disagreement with the Company. Also, effective August 8, 2025,…
Results of Operations and Financial Condition. On August 5, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended June 30, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended June 30, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including…
The issuance of the Common Stock is made in reliance upon an exemption provided under Section 4(a)(2) of the Securities Act of 1933, as amended.
ENTRY INTO OR AMENDMENT OF A MATERIAL DEFINITIVE AGREEMENT. Background As previously reported by OrthoPediatrics Corp. (the “Company”) in a Current Report on Form 8-K filed with the Securities and Exchange Commission on May 1, 2023, the Company entered into a Membership Interest Purchase Agreement dated May 1, 2023 (the “Purchase Agreement”) with Kevin Unger and DINZE LLC, an Ohio limited liability company (collectively, the “Sellers”), and the sole member of DINZE LLC, providing for the purc…
Results of Operations and Financial Condition. On May 7, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter ended March 31, 2025 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter ended March 31, 2025, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02, including…
Results of Operations and Financial Condition. On March 4, 2025, OrthoPediatrics Corp. issued a press release announcing its earnings for the quarter and year ended December 31, 2024 and making other disclosures. The press release (including the accompanying unaudited condensed consolidated financial statements as of and for the quarter and year ended December 31, 2024, and other financial data) is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.